Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Wahrmann

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Journal of Immunological Methods|April 2, 2003
Flow cytometry based detection of HLA alloantibody mediated classical complement activationMarkus Wahrmann, Markus Exner, Heinz Regele, et al.
Clinical Biochemistry|June 30, 2015
Detection of alloantibody-mediated complement activation: A diagnostic advance in monitoring kidney transplant rejection?Georg A Böhmig, Zeljko Kikic, Markus Wahrmann, et al.
Scientific Reports|October 21, 2017
Longitudinal assessment of HLA and MIC-A antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetesLorenz Küssel, Harald Herkner, Markus Wahrmann, et al.
Frontiers in Immunology|September 9, 2021
Functional Fc Gamma Receptor Gene Polymorphisms and Long-Term Kidney Allograft SurvivalMarkus Wahrmann, Bernd Döhler, Marie-Luise Arnold, et al.
Wiener Klinische Wochenschrift|July 26, 2006
Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathyChristoph Schwarz, Heinz Regele, Nicole Huttary, et al.
Journal of Medical Virology|November 6, 2024
Torque Teno Virus Control by the Classical Pathway of Complement Activation-A Retrospective Analysis From a First-in-Human Trial Utilizing SutimlimabSebastian Kapps, Jakob Mühlbacher, Dorian Kulifaj, et al.
Frontiers in Immunology|October 2, 2019
Neuropilin-1 Acts as a Receptor for Complement Split ProductsClaire Battin, Annika De Sousa Linhares, Wolfgang Paster, et al.
Transplantation Direct|July 24, 2019
Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated RejectionBlanka Mező, Andreas Heilos, Georg A Böhmig, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 5, 2013
Clinicopathological relevance of granular C4d deposition in peritubular capillaries of kidney allograftsZeljko Kikić, Nicolas Kozakowski, Heinz Regele, et al.
Clinical Transplants|August 19, 2015
Late Antibody-Mediated Rejection in a Large Prospective Cross-Sectional Study of Kidney Allograft Recipients--Preliminary Results of the Screening Phase of the BORTEJECT TrialFarsad Eskandary, Gregor Bond, Heinz Regele, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Journal of Immunological Methods|April 2, 2003
Flow cytometry based detection of HLA alloantibody mediated classical complement activationMarkus Wahrmann, Markus Exner, Heinz Regele, et al.
Clinical Biochemistry|June 30, 2015
Detection of alloantibody-mediated complement activation: A diagnostic advance in monitoring kidney transplant rejection?Georg A Böhmig, Zeljko Kikic, Markus Wahrmann, et al.
Scientific Reports|October 21, 2017
Longitudinal assessment of HLA and MIC-A antibodies in uneventful pregnancies and pregnancies complicated by preeclampsia or gestational diabetesLorenz Küssel, Harald Herkner, Markus Wahrmann, et al.
Frontiers in Immunology|September 9, 2021
Functional Fc Gamma Receptor Gene Polymorphisms and Long-Term Kidney Allograft SurvivalMarkus Wahrmann, Bernd Döhler, Marie-Luise Arnold, et al.
Wiener Klinische Wochenschrift|July 26, 2006
Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathyChristoph Schwarz, Heinz Regele, Nicole Huttary, et al.
Journal of Medical Virology|November 6, 2024
Torque Teno Virus Control by the Classical Pathway of Complement Activation-A Retrospective Analysis From a First-in-Human Trial Utilizing SutimlimabSebastian Kapps, Jakob Mühlbacher, Dorian Kulifaj, et al.
Frontiers in Immunology|October 2, 2019
Neuropilin-1 Acts as a Receptor for Complement Split ProductsClaire Battin, Annika De Sousa Linhares, Wolfgang Paster, et al.
Transplantation Direct|July 24, 2019
Complement Markers in Blood and Urine: No Diagnostic Value in Late Silent Antibody-Mediated RejectionBlanka Mező, Andreas Heilos, Georg A Böhmig, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 5, 2013
Clinicopathological relevance of granular C4d deposition in peritubular capillaries of kidney allograftsZeljko Kikić, Nicolas Kozakowski, Heinz Regele, et al.
Clinical Transplants|August 19, 2015
Late Antibody-Mediated Rejection in a Large Prospective Cross-Sectional Study of Kidney Allograft Recipients--Preliminary Results of the Screening Phase of the BORTEJECT TrialFarsad Eskandary, Gregor Bond, Heinz Regele, et al.
Pageof 7